AccuFusion™ RNA Lung Cancer Panel

AccuFusion™ RNA Lung Cancer Panel

For Research Use Only. Not for use in diagnostic procedures.

Known fusion detection and research via amplicon-based target enrichment for Next Generation Sequencing (NGS) on Illumina sequencing platforms

  • AccuFusion™ RNA Lung Cancer Panel uses a dual primer amplification method to enable focused detection of more than 280 known gene fusions associated with non-small cell lung cancer (NSCLC).

  • Fusion genes are associated with ALK, CIT, EML4, FGFR1, MBIP, MET, NRG1, NTRK1, NTRK3, PDGFRA, RET, ROS1, TACC3.

  • The AccuFusion dual-primer based amplification technology uses expertly designed and target specific primers to generate libraries without fragmentation of the input material.

  • Compared to other methods such as qPCR, FISH, or Sanger sequencing, Paragon Genomics targeted fusion sequencing method allows robust multiplexed detection of variants using minimum sample input and a simple workflow.

Fast and reliable assay for detecting known gene fusions

Sensitive Detection

Can detect down to 1% variant frequency with high confidence.

Excellent performance with high on-target rate

Prepare high-quality targeted NGS libraries using AccuFusion RNA Fusion Technology to achieve high on-target rate for efficient sequencing

Fast, streamlined workflow

Generate sequencing-ready libraries in just 6 hours using a rapid, four-step protocol from extracted RNA to sequence ready libraries.

Targeted identification of RNA fusions associated with lung cancer

Interrogate ~280 known RNA fusions using a target-specific dual-primer multiplex PCR method.

Specifications

SKU

Description

Pack Size

Get Quote
SKU
Description
Pack Size

917103

AccuFusion RNA Lung Cancer Panel

8 reactions

Get Quote
SKU
Description
Pack Size

917104

AccuFusion RNA Lung Cancer Panel

96 reaction

Get Quote
SKU
Description
Pack Size

917105

AccuFusion RNA Lung Cancer Panel

384 reaction

Get Quote
SKU
Description
Pack Size

716006

CleanPlex® Dual-Indexed PCR Primers for Illumina® Set A

96 indexes, 96 reactions

RNA Lung Cancer Panel
arrow&v
arrow&v
Cancel

Your content has been submitted

© 2021 Bioinnovations | Connecting Technologies to Life

Designed by Maveristic

Address

G1-G2, A-Wing, Hamirmal Tower, Station Rd, Bhayandar, Narayan Nagar, Bhayandar West, Mumbai, Maharashtra 401101, India

Quick Links